publication venue for
- High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy.. 8. 2003
- Emerging drugs for the treatment of benign prostatic hyperplasia. 2017
- Emerging mAbs for the treatment of esophagogastric cancer. 2014
- Emerging protein kinase inhibitors for non-small cell lung cancer. 2013
- Emerging treatments for chronic constipation. 2013
- Emerging tyrosine kinase inhibitors for esophageal cancer. 2013
- Emerging anti-inflammatory drugs for atherosclerosis. 2013
- Emerging pharmacotherapy for obesity. 2011
- Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. 2005